| Literature DB >> 30961948 |
William H Amundson1, Emilian Racila2, Tadashi Allen3, H Erhan Dincer1, Rade Tomic4, Maneesh Bhargava1, David M Perlman1, Hyun Joo Kim5.
Abstract
Interstitial lung disease (ILD) is a category of diffuse parenchymal lung diseases characterized by inflammation and/or fibrosis. The best characterized ILD is idiopathic pulmonary fibrosis (IPF). Acute exacerbation of IPF is a dreaded occurrence with grim prognosis and suboptimal treatment options. There have been recent reports that acute exacerbation can occur in other ILDs (AE-ILD). Of note, some of these acute exacerbations follow lung procedures. This review summarizes the available information on AE-ILD and discusses the procedures reported to cause AE-ILD. We also discuss proposed mechanisms, risk factors, treatment and prognosis. This review should help to inform decision-making about risks versus benefits of procedures that are commonly recommended to diagnose ILD.Entities:
Keywords: AE-ILD; Acute exacerbation; Acute exacerbation of interstitial lung disease; Interstitial lung disease; Lung biopsy
Mesh:
Year: 2019 PMID: 30961948 DOI: 10.1016/j.rmed.2019.02.012
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415